Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

plerixafor MeSH Supplementary Concept Data 2025


MeSH Supplementary
plerixafor
Unique ID
C088327
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C088327
Entry Term(s)
1,1'-(1,4-phenylenebis(methylene))bis(1,4,8,11-tetraazacyclotetradecane)octahydrochloride dihydrate
1,1'-(1,4-phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane
1,1'-(1,4-phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride dihydrate
AMD 3100
AMD 3329
AMD-3100
AMD-3329
AMD3100
JM 3100
JM3100
RPA bicyclam
mezobil
mozobil
plerixafor hydrochloride
plerixafor octahydrobromide
plerixafor octahydrochloride
Pharm Action
Anti-HIV Agents
Registry Numbers
S915P5499N
0
3EUZ070LLN
OD49913540
S79I522MQB
Related Numbers
3EUZ070LLN
OD49913540
S79I522MQB
Heading Mapped to
*Benzylamines
*Cyclams
Frequency
1308
Note
a bicyclam derivate, highly potent & selective inhibitor of HIV-1 & HIV-2
Source
Antimicrob Agents Chemother 1994 Apr;38(4):668-74
Date of Entry
1994/08/10
Revision Date
2021/03/24
plerixafor Preferred
1,1'-(1,4-phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride dihydrate Narrower
AMD 3329 Narrower
plerixafor octahydrochloride Narrower
plerixafor octahydrobromide Narrower
page delivered in 0.007s